Maria A Papadaki
Overview
Explore the profile of Maria A Papadaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadaki M, Papadaki E, Chatziavraam S, Aggouraki D, Michaelidou K, Fotsitzoudis C, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272785
The Fas/Fas ligand (FasL) system is a major apoptosis-regulating pathway with a key role in tumor immune surveillance and metastasis. The expression of Fas/FasL on mammary tumor tissues holds prognostic...
2.
Michaelidou K, Karniadakis I, Pantelaion V, Koutoulaki C, Boukla E, Folinas K, et al.
Expert Rev Mol Diagn
. 2024 Jan;
24(1-2):89-98.
PMID: 38193169
Background: Limited information exists on epidermal growth factor receptor molecular epidemiology in Greece. Next-generation sequencing (NGS) is the recommended method for genotyping in NSCLC. The Idylla Biocartis platform is a...
3.
Monastirioti A, Papadaki C, Kalapanida D, Rounis K, Michaelidou K, Papadaki M, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230658
Since circulating microRNAs (miRNAs) are involved in the modulation of the immune response, they are tested as liquid biopsy-based biomarkers in patients with NSCLC treated with immunotherapy. We analyzed the...
4.
Papadaki M, Mala A, Merodoulaki A, Vassilakopoulou M, Mavroudis D, Agelaki S
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010896
We herein aimed to assess the effect of eribulin mesylate on the cancer stem cell (CSC)/EMT-like phenotype of CTCs, and to investigate the prognostic role of CTC detection and monitoring...
5.
Papadaki M, Agelaki S
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267622
Metastasis remains the main cause of death for breast cancer (BC) patients, and conceivably, a huge effort has been directed toward the understanding of the metastatic process [...].
6.
Papadaki M, Monastirioti A, Apostolopoulou C, Aggouraki D, Papadaki C, Michaelidou K, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205801
TLR4 and pSTAT3 are key players in cancer inflammation and immune evasion; however, their role in the peripheral blood (PB) is largely unexplored. Herein we evaluated their expression in the...
7.
Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki M, Rounis K, et al.
Biomedicines
. 2021 Apr;
9(4).
PMID: 33924670
MicroRNAs (miRNAs) are involved in the regulation of immune response and hold an important role in tumor immune escape. We investigated the differential expression of the immunomodulatory miR-10b, miR-19a, miR-20a,...
8.
Papadaki M, Aggouraki D, Vetsika E, Xenidis N, Kallergi G, Kotsakis A, et al.
Anticancer Res
. 2021 Jan;
41(2):661-670.
PMID: 33517270
Background: To investigate the correlation between circulating tumor cells (CTCs) bearing cancer stem cell (CSC) and epithelial-to-mesenchymal (EMT) phenotypes and the different immunosuppressive cells in peripheral blood of patients with...
9.
Papadaki M, Messaritakis I, Fiste O, Souglakos J, Politaki E, Kotsakis A, et al.
Int J Mol Sci
. 2021 Jan;
22(2).
PMID: 33477700
We herein investigated the detection frequency and clinical relevance of circulating tumor cells (CTCs) in chemotherapy-naïve stage IIIB/IV non-small cell lung cancer (NSCLC), by using the CellSearch and real-time CEACAM5mRNA...
10.
Polioudaki H, Mala A, Gkimprixi E, Papadaki M, Chantziou A, Tzardi M, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33322610
We aimed to evaluate the co-expression of PD-L1 and epithelial-mesenchymal markers in CTCs from metastatic breast cancer (MBC) patients and to determine if there is any relationship with patients' outcome...